Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    BTTC 11-01
Previous Study | Return to List | Next Study

Lacosamide for Seizure Prophylaxis in High-Grade Gliomas

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Brain Tumor Trials Collaborative
UCB Pharma
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01432171
First received: September 8, 2011
Last updated: May 24, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)